Vitamin D Treatment Modulates Immune Activation in Cystic Fibrosis.

Pincikova T., et al.
Clinical & Experimental Immunology, 2017

Abstract

Persistent inflammatory response in cystic fibrosis (CF) airways is believed to play a central role in the progression of lung damage. Anti-inflammatory treatment may slow lung disease progression, but adverse side effects have limited its use. Vitamin D has immunoregulatory properties. We randomized 16 CF patients to receive vitamin D2, vitamin D3 or to serve as controls, and investigated the effect of vitamin D supplementation on soluble immunological parameters, myeloid dendritic cells (mDCs) and T cell activation. Three months of vitamin D treatment were followed by two washout months. Vitamin D status at baseline was correlated negatively with haptoglobin, erythrocyte sedimentation rate and immunoglobulin A concentration. Total vitamin D dose per kg bodyweight correlated with the down-modulation of the co-stimulatory receptor CD86 on mDCs. Vitamin D treatment was associated with reduced CD279 (PD-1) expression on CD4+ and CD8+ T cells, as well as decreased frequency of CD8+ T cells co-expressing the activation markers CD38 and human leucocyte antigen D-related (HLA-DR) in a dose-dependent manner. There was a trend towards decreased mucosal-associated invariant T cells (MAIT) cell frequency in patients receiving vitamin D and free serum 25-hydroxyvitamin D (free-s25OHD) correlated positively with CD38 expression by these cells. At the end of intervention, the change in free-s25OHD was correlated negatively with the change in CD279 (PD-1) expression on MAIT cells. Collectively, these data indicate that vitamin D has robust pleiotropic immunomodulatory effects in CF. Larger studies are needed to explore the immunomodulatory treatment potential of vitamin D in CF in more detail.

Trial registration

ClinicalTrials.gov NCT01321905.

Keywords

T cells; cystic fibrosis; immunity; immunoglobulins; vitamin D.

© 2017 British Society for Immunology.

PMID:28470739
DOI:PMC5543500
PMCID (Free PMC Article):10.1111/cei.12984
Category:Allergy / Immune

The best supplements with Cholecalciferol in Allergy / Immune category:

Articles similar to "Vitamin D Treatment Modulates Immune Activation in Cystic Fibrosis."

  • The significance of Cholecalciferol for Allergy / Immune: Regulation of Immune Function by Vitamin D and Its Use in Diseases of Immunity. (Evidence exists for a role for vitamin D and its active metabolites in modulating immune functions...)
  • The role of Cholecalciferol in Allergy / Immune: Nutrigenomics of Vitamin D. (Nutrigenomics studies how environmental factors, such as food intake and lifestyle, influence the expression of the genome...)
  • The impact of Cholecalciferol on Allergy / Immune: Vitamin D Supplementation During Pregnancy: Effect on the Neonatal Immune System in a Randomized Controlled Trial. ( Programming of the immune system during fetal development can influence asthma-related risk factors and outcomes in later life... Vitamin D exposure during fetal development influences the immune system of the neonate, which can contribute to protection from asthma-related, including infectious, outcomes in early life. Trial registration: ClinicalTrials.gov NCT00920621. )
  • The significance of Cholecalciferol for Allergy / Immune: The Active Metabolite of Vitamin D3 as a Potential Immunomodulator. (In the past, vitamin D was known for its classical, skeletal action as a regulator of calcium and bone homoeostasis... Vitamin D exposure during fetal development influences the immune system of the neonate, which can contribute to protection from asthma-related, including infectious, outcomes in early life. Trial registration: ClinicalTrials.gov NCT00920621. )

Previous article

The Active Metabolite of Vitamin D3 as a Potential Immunomodulator.

Next article

Nutrigenomics of Vitamin D.